Public Health Services Act; Delegation of Authority, 27348 [2010-11406]
Download as PDF
<![CDATA[
27348
Federal Register / Vol. 75, No. 93 / Friday, May 14, 2010 / Notices
submitted under § 606.171. CBER
estimates that 5 percent of the total BPD
reports submitted to CBER under
§ 606.171 would need additional
information submitted in the
addendum. CBER further estimates that
it would take between 10 and 20
minutes to complete the addendum. For
calculation purposes, CBER is using 15
minutes.
Activities such as investigating,
changing standard operating procedures
or processes, and follow-up are
currently required under 21 CFR parts
211 (approved under OMB control
number 0910–0139), 606 (approved
under OMB control number 0910–0116),
820 (approved under OMB control
number 0910–0073), and 1271
(approved under OMB control number
0910–0543) and, therefore, are not
included in the burden calculation for
the separate requirement of submitting a
deviation report to FDA.
In the Federal Register of November
18, 2009 (74 FR 59556), FDA published
a 60-day notice requesting public
comment on the proposed collection of
information. No comments were
received on the information collection.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
21 CFR
Section
FDA
Form No.
No. of
Respondents
Annual Frequency
per Response
Total Annual
Responses
Hours per
Response
Total Hours
600.14
3486
51
7.78
397
2.0
794
606.171
3486
1,533
28.78
44,120
2.0
88,240
1271.350(b)
3486
84
2.64
222
2.0
444
3486A2
77
28.65
2,206
0.25
551.5
Total
90,029.5
1 There
2 Five
are no capital costs or operating and maintenance costs associated with this collection of information.
percent of the number of respondents (1,533 x 0.05 = 77) and total annual responses to CBER (44,125 x 0.05 = 2,206).
Dated: May 10, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
Directive 21 to share stockpiled assets
with other federal government
organizations when the material will be
replaced by the receiving organization.
This delegation became effective upon
date of signature. I hereby affirm and
ratify any actions taken by the Director,
OPHPR, which involve the exercise of
these authorities prior to the effective
date of this delegation.
[FR Doc. 2010–11541 Filed 5–13–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
emcdonald on DSK2BSOYB1PROD with NOTICES
Public Health Services Act; Delegation
of Authority
Notice is hereby given that I have
delegated to the Director, Office of
Public Health Preparedness and
Response (OPHPR), with authority to
redelegate, the authority to:
• Release small quantities of any
material from the Strategic National
Stockpile (SNS) to provide intervention
for specific individual conditions and
the coordination of transportation assets
to meet required deadlines.
• Release small quantities of any
material from the SNS for testing and
evaluation or to support governmentrequired programs of vaccinations for
persons at risk for specific conditions as
a result of government job requirements.
• Advance deploy any material from
the SNS to remain under CDC control
without release to other government or
non-government organizations in order
to prepare for possible response needs
• Release any material from the SNS
to comply with requirements as set forth
by Homeland Security Presidential
VerDate Mar<15>2010
18:07 May 13, 2010
Jkt 220001
Dated: April 26, 2010.
Thomas Frieden,
Director, CDC.
[FR Doc. 2010–11406 Filed 5–13–10; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
AGENCY: Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
SUMMARY: The Department of Health and
Human Services (HHS) notifies Federal
agencies of the laboratories currently
certified to meet the standards of
Subpart C of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908),
on September 30, 1997 (62 FR 51118),
and on April 13, 2004 (69 FR 19644).
A notice listing all currently certified
laboratories is published in the Federal
Register during the first week of each
month. If any laboratory’s certification
is suspended or revoked, the laboratory
will be omitted from subsequent lists
until such time as it is restored to full
certification under the Mandatory
Guidelines.
If any laboratory has withdrawn from
the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end,
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://
www.workplace.samhsa.gov and https://
www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs.
Giselle Hersh, Division of Workplace
Programs, SAMHSA/CSAP, Room 2–
1042, One Choke Cherry Road,
Rockville, Maryland 20857; 240–276–
2600 (voice), 240–276–2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were developed
in accordance with Executive Order
12564 and section 503 of Pub. L. 100–
71. Subpart C of the Mandatory
Guidelines, ‘‘Certification of
Laboratories Engaged in Urine Drug
Testing for Federal Agencies,’’ sets strict
standards that laboratories must meet in
order to conduct drug and specimen
E:\FR\FM\14MYN1.SGM
14MYN1
]]>Agencies
[Federal Register Volume 75, Number 93 (Friday, May 14, 2010)]
[Notices]
[Page 27348]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-11406]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Public Health Services Act; Delegation of Authority
Notice is hereby given that I have delegated to the Director,
Office of Public Health Preparedness and Response (OPHPR), with
authority to redelegate, the authority to:
Release small quantities of any material from the
Strategic National Stockpile (SNS) to provide intervention for specific
individual conditions and the coordination of transportation assets to
meet required deadlines.
Release small quantities of any material from the SNS for
testing and evaluation or to support government-required programs of
vaccinations for persons at risk for specific conditions as a result of
government job requirements.
Advance deploy any material from the SNS to remain under
CDC control without release to other government or non-government
organizations in order to prepare for possible response needs
Release any material from the SNS to comply with
requirements as set forth by Homeland Security Presidential Directive
21 to share stockpiled assets with other federal government
organizations when the material will be replaced by the receiving
organization.
This delegation became effective upon date of signature. I hereby
affirm and ratify any actions taken by the Director, OPHPR, which
involve the exercise of these authorities prior to the effective date
of this delegation.
Dated: April 26, 2010.
Thomas Frieden,
Director, CDC.
[FR Doc. 2010-11406 Filed 5-13-10; 8:45 am]
BILLING CODE 4160-18-M
